Gene · 407009
Papers2,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of exosomes in the development, diagnosis, prognosis and treatment of hepatocellular carcinoma. | Mol Med | 2023 | 37848835 | PubTator, text mining | PubMed |
| Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer. | Int J Mol Sci | 2023 | 37834162 | PubTator, text mining | PubMed |
| miRNA Studies in Glaucoma: A Comprehensive Review of Current Knowledge and Future Perspectives. | Int J Mol Sci | 2023 | 37834147 | PubTator, text mining | PubMed |
| Retracted: Ginkgolide A Participates in LPS-Induced PMVEC Injury by Regulating miR-224 and Inhibiting p21 in a Targeted Manner. | Contrast Media Mol Imaging | 2023 | 37810504 | PubTator, text mining | PubMed |
| Construction of ceRNA network and identification of hub differentially expressed genes associated with breast cancer using reanalysis of microarray dataset: A systems biology approach. | Pathol Res Pract | 2023 | 37804544 | PubTator, text mining | PubMed |
| Exosomes in the Diagnosis and Treatment of Renal Cell Cancer. | Int J Mol Sci | 2023 | 37762660 | PubTator, text mining | PubMed |
| Autophagy Modulation as a Potential Therapeutic Strategy in Osteosarcoma: Current Insights and Future Perspectives. | Int J Mol Sci | 2023 | 37762129 | PubTator, text mining | PubMed |
| Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques. | Cancers (Basel) | 2023 | 37760539 | PubTator, text mining | PubMed |
| Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications. | Cancers (Basel) | 2023 | 37760490 | PubTator, text mining | PubMed |
| Identification of memory B-cell-associated miRNA signature to establish a prognostic model in gastric adenocarcinoma. | J Transl Med | 2023 | 37735667 | PubTator, text mining | PubMed |
| A possible genetic association between obesity and colon cancer in females. | Front Endocrinol (Lausanne) | 2023 | 37711894 | PubTator, text mining | PubMed |
| The macrophage polarization by miRNAs and its potential role in the treatment of tumor and inflammation (Review). | Oncol Rep | 2023 | 37711048 | PubTator, text mining | PubMed |
| MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected. | J Mol Med (Berl) | 2023 | 37704856 | PubTator, text mining | PubMed |
| MicroRNAs Regulate Tumorigenesis by Downregulating SOCS3 Expression: An In silico Approach. | Bioinform Biol Insights | 2023 | 37701630 | PubTator, text mining | PubMed |
| Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice. | Cancers (Basel) | 2023 | 37686621 | PubTator, text mining | PubMed |
| Extracellular Vesicles-A Source of RNA Biomarkers for the Detection of Breast Cancer in Liquid Biopsies. | Cancers (Basel) | 2023 | 37686605 | PubTator, text mining | PubMed |
| Effective Use of microRNA, BRAF and Sonographic Risk Assessment in Bethesda III Thyroid Nodules Requires a Different Approach to Nodules with Features of Nuclear Atypia and Other Types of Atypia. | Cancers (Basel) | 2023 | 37686562 | PubTator, text mining | PubMed |
| Research Advances in the Role of the Tropomyosin Family in Cancer. | Int J Mol Sci | 2023 | 37686101 | PubTator, text mining | PubMed |
| Predictive Role of Pretreatment Circulating miR-221 in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. | Diagnostics (Basel) | 2023 | 37685331 | PubTator, text mining | PubMed |
| Investigating genomic, proteomic, and post-transcriptional regulation profiles in colorectal cancer: a comparative study between primary tumors and associated metastases. | Cancer Cell Int | 2023 | 37670299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407009/papers?page=6